These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23844515)

  • 1. [Harnessing nature for treating infectious and autoimmune diseases: good and bad bacteria].
    Israeli E; Shoenfeld Y
    Harefuah; 2013 Apr; 152(4):188-9, 249. PubMed ID: 23844515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel avenues for Clostridium difficile infection drug discovery.
    Zucca M; Scutera S; Savoia D
    Expert Opin Drug Discov; 2013 Apr; 8(4):459-77. PubMed ID: 23427910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation in the treatment of Clostridium difficile infections.
    Austin M; Mellow M; Tierney WM
    Am J Med; 2014 Jun; 127(6):479-83. PubMed ID: 24582877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea.
    Rohde CL; Bartolini V; Jones N
    Nutr Clin Pract; 2009; 24(1):33-40. PubMed ID: 19244146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection.
    Brandt LJ
    Am J Gastroenterol; 2013 Feb; 108(2):177-85. PubMed ID: 23318479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
    Vindigni SM; Broussard EK; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
    McFarland LV
    Anaerobe; 2009 Dec; 15(6):274-80. PubMed ID: 19825425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pseudomembranous colitis: pathogenesis, prevention, treatment].
    Zakharova NV; Fil' TS
    Eksp Klin Gastroenterol; 2013; (12):87-91. PubMed ID: 24933996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The microbiota and infectious diarrhea].
    Surawicz CM
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S29-36. PubMed ID: 20889002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.
    Patel NC; Griesbach CL; DiBaise JK; Orenstein R
    Mayo Clin Proc; 2013 Aug; 88(8):799-805. PubMed ID: 23910407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between Lactobacilli and antibiotic-associated diarrhea.
    Naaber P; Mikelsaar M
    Adv Appl Microbiol; 2004; 54():231-60. PubMed ID: 15251283
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR; de Leon L; Jasutkar N
    J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
    Surawicz CM
    Chemotherapy; 2005; 51 Suppl 1():81-9. PubMed ID: 15855751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal transplant in refractory Clostridium difficile colitis.
    Kleger A; Schnell J; Essig A; Wagner M; Bommer M; Seufferlein T; Härter G
    Dtsch Arztebl Int; 2013 Feb; 110(7):108-15. PubMed ID: 23468820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation for recurrent clostridium difficile infection.
    Brandt LJ; Reddy SS
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S159-67. PubMed ID: 21992957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis.
    Friedman G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):763-79. PubMed ID: 23101686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.